Literature DB >> 24570318

Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India.

Rajib Saha1, Indranil Saha, Aditya Prasad Sarkar, Dilip Kumar Das, Raghunath Misra, Krishnadas Bhattacharya, Rabindra Nath Roy, Abantika Bhattacharya.   

Abstract

INTRODUCTION: The introduction of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) has led to the reduction of mortality and the improvement of the quality of life of people living with HIV/AIDS (PLWHA). The present study was conducted to determine the pattern of adherence to HAART among PLWHA, and to assess the factor(s) affecting nonadherence, if any.
METHODS: This study was a hospital-based analytical, cross-sectional epidemiological study conducted between July and October 2011. A total of 370 adult HIV-positive patients registered in the Antiretroviral Therapy Centre of Burdwan Medical College and Hospital, West Bengal, India, were included. Nonadherence was defined as missing at least a single dose of medicine within the last four days. Data was analysed using the Statistical Package for the Social Sciences version 19.0 (IBM Corp, Armonk, NY, USA).
RESULTS: A total of 87.6% of patients were found to be adherent to HAART. Principal causes of nonadherence were forgetting to take medicine (70.2%), being away from home (65.2%), and busyness with other things (64.7%). Multivariate logistic regression analysis revealed that nonadherence was significantly associated with a positive family history of HIV/AIDS (odds ratio [OR] 16; 95% confidence interval [CI] 2.2-114.3; p = 0.01), occurrence of side effects with HAART (OR 9.81; 95% CI 1.9-51.7; p = 0.01) and employment (OR 5.93; 95% CI 1.5-23.2; p = 0.01).
CONCLUSION: Although overall adherence was high, the factors that affect nonadherence can be addressed with proper counselling and motivation of patients and their family members. Adherence to HAART could delay the progression of this lethal disease and minimise the risk of developing drug resistance.

Entities:  

Mesh:

Year:  2014        PMID: 24570318      PMCID: PMC4291929          DOI: 10.11622/smedj.2014021

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  30 in total

1.  Adherence to HAART and its principal determinants in a cohort of Senegalese adults.

Authors:  Isabelle Lanièce; Mounirou Ciss; Alice Desclaux; Karim Diop; Fatou Mbodj; Barra Ndiaye; Omar Sylla; Eric Delaporte; Ibrahima Ndoye
Journal:  AIDS       Date:  2003-07       Impact factor: 4.177

Review 2.  Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance.

Authors:  Sally Blower; Li Ma; Paul Farmer; Serena Koenig
Journal:  Curr Drug Targets Infect Disord       Date:  2003-12

Review 3.  Once-daily HAART: toward a new treatment paradigm.

Authors:  Ian Frank
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

4.  'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.

Authors:  T S Barfod; H T Sørensen; H Nielsen; L Rodkjaer; N Obel
Journal:  HIV Med       Date:  2006-07       Impact factor: 3.180

5.  Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.

Authors:  Franco Maggiolo; Laura Ravasio; Diego Ripamonti; Giampietro Gregis; Giampaolo Quinzan; Claudio Arici; Monica Airoldi; Fredy Suter
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

6.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

7.  ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India.

Authors:  S A Safren; N Kumarasamy; R James; S Raminani; S Solomon; Kenneth H Mayer
Journal:  AIDS Care       Date:  2005-10

8.  Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

Authors:  Louise C Ivers; David Kendrick; Karen Doucette
Journal:  Clin Infect Dis       Date:  2005-05-27       Impact factor: 9.079

9.  An examination of HIV/AIDS patients who have excellent adherence to HAART.

Authors:  S E Malcolm; J J Ng; R K Rosen; V E Stone
Journal:  AIDS Care       Date:  2003-04

10.  Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

Authors:  Hiroyuki Gatanaga; Tsunefusa Hayashida; Kiyoto Tsuchiya; Munehiro Yoshino; Takeshi Kuwahara; Hiroki Tsukada; Katsuya Fujimoto; Isao Sato; Mikio Ueda; Masahide Horiba; Motohiro Hamaguchi; Masahiro Yamamoto; Noboru Takata; Akiro Kimura; Takao Koike; Fumitake Gejyo; Shuzo Matsushita; Takuma Shirasaka; Satoshi Kimura; Shinichi Oka
Journal:  Clin Infect Dis       Date:  2007-09-24       Impact factor: 9.079

View more
  10 in total

1.  Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.

Authors:  Michael Hoffmann; Sarah MacCarthy; Ashley Batson; Ann Crawford-Roberts; Jennifer Rasanathan; Amy Nunn; Luis Augusto Silva; Ines Dourado
Journal:  AIDS Care       Date:  2015-08-20

Review 2.  Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis.

Authors:  Jean B Nachega; Olalekan A Uthman; Karl Peltzer; Lindsey A Richardson; Edward J Mills; Kofi Amekudzi; Alice Ouédraogo
Journal:  Bull World Health Organ       Date:  2014-10-30       Impact factor: 9.408

3.  Nonadherence to Antiretroviral Therapy Among People Living with HIV/AIDS Attending Two Tertiary Care Hospitals in District of Northern India.

Authors:  Mukesh Shukla; Monika Agarwal; Jai Vir Singh; Anil Kumar Tripathi; Anand Kumar Srivastava; Vijay Kumar Singh
Journal:  Indian J Community Med       Date:  2016 Jan-Mar

4.  The relationship between patient-related factors and medication adherence among Nigerian patients taking highly active anti-retroviral therapy.

Authors:  Sabina O Nduaguba; Rebecca O Soremekun; Olubusola A Olugbake; Jamie C Barner
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

5.  World Health Organization Dimensions of Adherence to Antiretroviral Therapy: A Study at Antiretroviral Therapy Centre, Aligarh.

Authors:  Yasir Alvi; Najam Khalique; Anees Ahmad; Haroon Subhan Khan; Nafis Faizi
Journal:  Indian J Community Med       Date:  2019 Apr-Jun

6.  Determinants contributing for poor adherence to antiretroviral therapy: A hospital record-based study in Balasore, Odisha.

Authors:  Mallicka Gupta; Sai Chandan Das
Journal:  J Family Med Prim Care       Date:  2019-05

7.  [Determinants of non-compliance with antiretroviral therapy in adult patients in Kinshasa].

Authors:  Benilde Bepouka Izizag; Hippolyte Situakibanza; Florian Kiazayawoko; Aliocha Nkodila; Eric Mafuta; Philippe Lukanu; Henry Mukumbi; Murielle Longokolo; Madone Mandina; Nadine Mayasi; Amede Kinuka; Evelyne Amaela; Willy Kazadi; Marcel Mbula
Journal:  Pan Afr Med J       Date:  2020-10-14

8.  Legal knowledge, needs, and assistance seeking among HIV positive and negative women in Umlazi, South Africa.

Authors:  Lauren M Hill; Suzanne Maman; David Holness; Dhayendre Moodley
Journal:  BMC Int Health Hum Rights       Date:  2016-01-22

9.  High-risk sexual behavior among people living with HIV/AIDS attending tertiary care hospitals in district of Northern India.

Authors:  Mukesh Shukla; Monica Agarwal; Jai Vir Singh; Anil Kumar Tripathi; Anand Kumar Srivastava; Vijay Kumar Singh
Journal:  Indian J Sex Transm Dis AIDS       Date:  2016 Jan-Jun

10.  Non-adherence to anti-retroviral medication in Shiraz, 2014: a cross sectional study.

Authors:  Nasrin Motazedian; Mehrab Sayadi; Ali Firoozbakhtian
Journal:  Afr Health Sci       Date:  2018-06       Impact factor: 0.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.